Key result
In patients with NSTE-ACS and acute heart failure, dyspnoea at rest was strongly associated with higher in-hospital mortality compared to no dyspnoea (OR 5.79; 95% CI 2.56-13.11; P<.001).
Why the study?
Does the severity of self-reported dyspnoea predict in-hospital mortality and major adverse events in patients with NSTE-ACS complicated by acute heart failure?
Cohort (n=3,287)
Yes
Does the severity of self-reported dyspnoea predict in-hospital mortality and major adverse events in patients with NSTE-ACS complicated by acute heart failure?
Odds Ratio: 5.79 (95% CI 2.56–13.11)
p-value: p=<.001
In patients with NSTE-ACS complicated by acute heart failure, the severity of self-reported dyspnoea is strongly and independently associated with increased in-hospital mortality and major cardiovascular and renal events.
May aid in-hospital risk stratification in NSTE-ACS with acute HF; hypothesis-generating pending prospective validation.
BACKGROUND: Degree of dyspnoea is almost universally evaluated in the patients presenting with acute coronary syndrome (ACS), but its clinical implications has not been thoroughly investigated. We aimed to describe the relationship between the severity of dyspnoea and in-hospital outcomes in patients with non-ST elevation ACS (NSTE-ACS) complicated with acute heart failure (AHF). METHODS: Between 2009 and 2014, 3287 consecutive patients with NSTE-ACS were enrolled in the Japanese prospective multicenter PCI registry. Patients complicated with AHF were subclassified based on the self-reported dyspnoea severity: no dyspnoeic symptoms, dyspnoea during moderate activity, mild activity or at rest. The recorded outcomes included in-hospital death, major cardiovascular (ie, cardiac death, shock, stroke or major bleeding) and renal events (ie, contrast-induced acute kidney injury [CI-AKI] or AKI requiring dialysis). RESULTS: In total, 441 (13.4%) patients had AHF upon presentation, including 76 (17.2%) with dyspnoea during moderate activity, 160 (36.3%) with dyspnoea during mild activity, and 205 (46.5%) with dyspnoea at rest. In-hospital mortality as well as major cardiovascular and renal events increased as dyspnoea severity worsened. After multivariate adjustment, dyspnoea at rest was strongly associated with in-hospital mortality (odds ratio [OR] 5.79; 95% confidence interval [CI], 2.56-13.11; P<.001) as well as major cardiovascular (OR, 2.55; 95% CI, 1.46-4.48; P<.001) and renal events (OR, 3.32; 95% CI, 2.05-5.38; P<.001), when compared to the patients without dyspnoea. CONCLUSIONS: Among NSTE-ACS patients complicated with AHF, both cardiovascular and renal event rates were associated with presence of dyspnoea, and its incidence increased in parallel with dyspnoea severity.
No takes yet. Share an insight, caveat, or question.
Shiraishi et al. (2016) conducted a cohort in Non-ST-elevation acute coronary syndrome (NSTE-ACS) complicated with acute heart failure (n=3,287). Dyspnoea at rest vs. No dyspnoea was evaluated on In-hospital mortality (OR 5.79, 95% CI 2.56-13.11, p=<.001). In patients with NSTE-ACS and acute heart failure, dyspnoea at rest was strongly associated with higher in-hospital mortality compared to no dyspnoea (OR 5.79; 95% CI 2.56-13.11; P<.001).
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: